Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical application of immune repertoire sequencing in solid organ transplant. | Front Immunol | 2023 | 36865546 | PubTator, text mining | PubMed |
| Immune checkpoint molecules in prevention and development of asthma. | Front Immunol | 2023 | 36865540 | PubTator, text mining | PubMed |
| Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. | Aging (Albany NY) | 2023 | 36863706 | PubTator, text mining | PubMed |
| β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma. | Cancer Gene Ther | 2023 | 36854895 | PubTator, text mining | PubMed |
| In Vitro Expansion of Vδ1+ T Cells from Cord Blood by Using Artificial Antigen-Presenting Cells and Anti-CD3 Antibody. | Vaccines (Basel) | 2023 | 36851283 | PubTator, text mining | PubMed |
| LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically 'Cold' KIRC Tumours. | Vaccines (Basel) | 2023 | 36851274 | PubTator, text mining | PubMed |
| Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits. | Sci Rep | 2023 | 36849551 | PubTator, text mining | PubMed |
| Prognostic roles of a novel basement membranes-related gene signature in lung adenocarcinoma. | Front Genet | 2023 | 36845403 | PubTator, text mining | PubMed |
| mRNA-Based Therapeutics in Cancer Treatment. | Pharmaceutics | 2023 | 36839944 | PubTator, text mining | PubMed |
| Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses. | Pharmaceutics | 2023 | 36839682 | PubTator, text mining | PubMed |
| A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. | Cancers (Basel) | 2023 | 36831427 | PubTator, text mining | PubMed |
| A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome. | Cells | 2023 | 36831300 | PubTator, text mining | PubMed |
| Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma. | Biology (Basel) | 2023 | 36829596 | PubTator, text mining | PubMed |
| Bacteria and macrophages in the tumor microenvironment. | Front Microbiol | 2023 | 36825088 | PubTator, text mining | PubMed |
| Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. | Oxid Med Cell Longev | 2023 | 36825082 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma. | J Immunother Cancer | 2023 | 36822672 | PubTator, text mining | PubMed |
| Mapping the interplay between NK cells and HIV: therapeutic implications. | J Leukoc Biol | 2023 | 36822173 | PubTator, text mining | PubMed |
| Landscape of costimulatory molecule signature in breast cancer and its prognostic significance. | Ann Transl Med | 2023 | 36819560 | PubTator, text mining | PubMed |
| Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. | Commun Biol | 2023 | 36805684 | PubTator, text mining | PubMed |
| A novel L-phenylalanine dipeptide inhibits prostate cancer cell proliferation by targeting TNFSF9. | Biomed Pharmacother | 2023 | 36804121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=28